Last reviewed · How we verify
NCT04828941: E-Migra
My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring
NA trial testing Electronic Headache Diary in Episodic Migraine in 60 participants. Status unknown.
2 October 2021
Quick facts
| Lead sponsor | Unidade Local de Saúde de Matosinhos, EPE |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 60 |
| Start date | 28 March 2021 |
| Primary completion | 2 October 2021 |
| Estimated completion | 1 November 2021 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Electronic Headache Diary
- Paper Diary
Conditions studied
- Episodic Migraine — all drugs for Episodic Migraine →
- Migraine Disorders — all drugs for Migraine Disorders →
Sponsor
Unidade Local de Saúde de Matosinhos, EPE
Who can join
Adults 18 to 50, any sex, with Episodic Migraine or Migraine Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the usefulness of an app-based headache diary in episodic migraine patients. For this the investigators will conduct a randomized clinical trial with a crossover design, using the app-based diary and a traditional paper-based headache diary. The patients will use each diary for 13 weeks. The investigators will evaluate diary adhesion after each 13-week period, and also evaluate headache burden and prophylactic medication compliance at the beginning, at the crossover point, and at the end of the study, and acute headache medication use through diary records. The investigators will also evaluate user preference through a questionnaire at the end of the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04828941
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Episodic Migraine
Currently open trials in the same condition.
- NCT07496034 — Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial · Phase 3 · recruiting
- NCT06229834 — Chiropractic Care for Episodic Migraine · NA · recruiting
- NCT06625060 — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · recruiting
- NCT06248671 — Prophylactic Treatment With Atorvastatin for Episodic Migraine. · Phase 2 · recruiting
- NCT06047457 — A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults · Phase 3 · active not recruiting
Other Unidade Local de Saúde de Matosinhos, EPE trials
Trials by the same sponsor.
- NCT06181474 — MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04828941 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unidade Local de Saúde de Matosinhos, EPE
- Last refreshed: 2 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04828941.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing